Johnson & Johnson (JNJ) Cost of Revenue (2009 - 2026)

Johnson & Johnson has disclosed Cost of Revenue across 18 years of filings, most recently posting $8.1 billion for Q2 2026.

• In Q2 2026, Cost of Revenue rose 5.55% year-over-year to $8.1 billion; the TTM figure through Jun 2026 stood at $31.4 billion (up 8.09% YoY), while the FY2025 annual figure was $30.3 billion, up 10.14% from the prior year.
• Cost of Revenue came in at $8.1 billion for Q2 2026 at Johnson & Johnson, down from $8.1 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $8.1 billion in Q1 2026 to a low of $2.7 billion in Q1 2023.
• Average Cost of Revenue over 5 years is $6.9 billion, with a median of $7.0 billion recorded in 2024.
• The largest YoY upside for Cost of Revenue was 152.15% in 2023 against a maximum downside of 18.4% in 2023.
• Over 5 years, Cost of Revenue stood at $6.2 billion in 2022, then increased by 10.14% to $6.8 billion in 2023, then grew by 4.85% to $7.1 billion in 2024, then increased by 11.78% to $8.0 billion in 2025, then gained by 1.04% to $8.1 billion in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $8.1 billion in Q2 2026, $8.1 billion in Q1 2026, and $8.0 billion in Q4 2025.